Andreas Metzner
Overview
Explore the profile of Andreas Metzner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
279
Citations
4386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lemoine M, Obergassel J, Jaeckle S, Nies M, Taraba S, Mencke C, et al.
Europace
. 2024 Aug;
26(9).
PMID: 39166530
Aims: Pulsed-field ablation (PFA) is an emerging technology to perform pulmonary vein isolation (PVI). Initial data demonstrated high safety and efficacy. Data on long-term PVI durability and reconduction patterns in...
12.
Boehmer A, Kaess B, Ruckes C, Meyer C, Metzner A, Rillig A, et al.
Can J Cardiol
. 2024 Jul;
40(12):2429-2440.
PMID: 39067619
Age is a major risk-factor for atrial fibrillation (AF) and associated hospitalisations. With increasing emphasis on rhythm control, pulmonary vein isolation (PVI) is often suggested, even to elderly patients (≥...
13.
Ekanem E, Neuzil P, Reichlin T, Kautzner J, van der Voort P, Jais P, et al.
Nat Med
. 2024 Jul;
30(7):2020-2029.
PMID: 38977913
Pulsed field ablation (PFA) is an emerging technology for the treatment of atrial fibrillation (AF), for which pre-clinical and early-stage clinical data are suggestive of some degree of preferentiality to...
14.
Becher N, Metzner A, Toennis T, Kirchhof P, Schnabel R
Eur Heart J
. 2024 Jul;
45(31):2824-2838.
PMID: 38953776
Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is not a dichotomous disease trait. Technological innovations enable long-term rhythm monitoring in many patients and can estimate AF burden. These...
15.
Turagam M, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner A, et al.
JACC Clin Electrophysiol
. 2024 Jun;
PMID: 38869506
Background: Atrial fibrillation (AF) and heart failure (HF) coexist, increasing morbidity and mortality. Studies have demonstrated improved outcomes following AF ablation in HF patients with reduced ejection fraction (EF). Objective:...
16.
Turagam M, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner A, et al.
JACC Clin Electrophysiol
. 2024 Jun;
PMID: 38864809
Background: Atrial fibrillation (AF) and heart failure (HF) coexist, increasing morbidity and mortality. Studies have demonstrated improved outcomes following AF ablation in HF patients with reduced ejection fraction (EF). Objective:...
17.
Reddy V, Langbein A, Petru J, Szili-Torok T, Funasako M, Dinshaw L, et al.
JACC Clin Electrophysiol
. 2024 Jun;
10(8):1856-1869.
PMID: 38842972
Background: Electrographic flow (EGF) mapping enables full spatiotemporal reconstruction of organized wavefront propagation to identify extrapulmonary vein sources of atrial fibrillation (AF). Objectives: FLOW-AF (A Randomized Controlled Study to Evaluate...
18.
Knappe D, Vogler J, Weimann J, Banas V, Obergassel J, Yildirim S, et al.
Circ J
. 2024 Jun;
89(2):153-161.
PMID: 38839350
Background: Achieving early rhythm control and maintaining sinus rhythm are associated with improved outcomes in patients with atrial fibrillation (AF). Pulmonary vein isolation (PVI) is a validated alternative to medical...
19.
Knappe D, Vogler J, Weimann J, Banas V, Yildirim S, Memenga F, et al.
Clin Res Cardiol
. 2024 May;
114(1):103-111.
PMID: 38771346
Aims: For patients with symptomatic drug-refractory atrial fibrillation (AF), catheter ablation to achieve rhythm control is an important therapeutic option. The atrial mechanical dispersion measured as standard deviation of the...
20.
Rillig A, Eckardt L, Borof K, Camm A, Crijns H, Goette A, et al.
Europace
. 2024 May;
26(6).
PMID: 38702961
Aims: Clinical concerns exist about the potential proarrhythmic effects of the sodium channel blockers (SCBs) flecainide and propafenone in patients with cardiovascular disease. Sodium channel blockers were used to deliver...